Your browser doesn't support javascript.
loading
Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study.
Van Cutsem, E; Muro, K; Cunningham, D; Bodoky, G; Sobrero, A; Cascinu, S; Ajani, J; Oh, S C; Al-Batran, S E; Wainberg, Z A; Wijayawardana, S R; Melemed, S; Ferry, D; Hozak, R R; Ohtsu, A.
Afiliação
  • Van Cutsem E; Digestive Oncology, University Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, Belgium. Electronic address: Eric.VanCutsem@uzleuven.be.
  • Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Cunningham D; Royal Marsden Hospital, Sutton, UK.
  • Bodoky G; Department of Oncology, St. László Hospital, Budapest, Hungary.
  • Sobrero A; Medical Oncology, IRCCS Ospedale San Martino IST, Genova, Italy.
  • Cascinu S; Department of Medical Oncology, Università Politecnica Delle Marche, Ancona, Italy.
  • Ajani J; Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Oh SC; Korea University Guro Hospital, Seoul, South Korea.
  • Al-Batran SE; Institute of Clinical Cancer Research (IKF), UCT- University Cancer Center, Frankfurt, Germany.
  • Wainberg ZA; Medical Hematology and Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Wijayawardana SR; Eli Lilly and Company, Indianapolis, IN, USA.
  • Melemed S; Eli Lilly and Company, Indianapolis, IN, USA.
  • Ferry D; Eli Lilly and Company, Bridgewater, NJ, USA.
  • Hozak RR; Eli Lilly and Company, Indianapolis, IN, USA.
  • Ohtsu A; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Eur J Cancer ; 127: 150-157, 2020 03.
Article em En | MEDLINE | ID: mdl-32014812
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Junção Esofagogástrica Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Junção Esofagogástrica Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2020 Tipo de documento: Article